Home › Chronic Kidney Disease › New Mexico
Chronic Kidney Disease clinical trials in New Mexico
8 studies for Chronic Kidney Disease are looking for participants at sites in New Mexico.
Cities in New Mexico
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
- First Nations Community Health Source, Albuquerque
- Zuni Health Initiative Center, Black Rock
RecruitingObservational study
Ages 21 to 80 · All sexes · Updated Oct 13, 2026 · NCT04185844A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
- Research Site, Albuquerque
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 24, 2026 · NCT07624305A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- Research Site, Albuquerque
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07753993Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients
- UNM, Albuquerque
Recruiting
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT06978127Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
- New Mexico VA Health Care System, Albuquerque, NM, Albuquerque
Recruiting
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT05465044NAVIGATE Kidney: A Multi-level Intervention to Reduce Kidney Health Disparities
- University of New Mexico Health Science Center, Albuquerque
Recruiting
Ages 18 to 75 · All sexes · Updated Jul 24, 2026 · NCT06810622Transformative Research in Diabetic Nephropathy
- University of New Mexico, Albuquerque
RecruitingObservational study
Ages 18 to 100 · All sexes · Updated Feb 27, 2026 · NCT02986984A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
- High Desert Nephrology Association - US Renal Care, Gallup
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Jan 29, 2026 · NCT06933472From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.